MFDS — authorised 6 March 2020
- Marketing authorisation holder: RECORDATI RARE
- Status: likely_approved
🇰🇷 Isturisa in South Korea
MFDS authorised Isturisa on 6 March 2020
Marketing authorisation
Isturisa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in South Korea
Frequently asked questions
Is Isturisa approved in South Korea?
Yes. MFDS authorised it on 6 March 2020.
Who is the marketing authorisation holder for Isturisa in South Korea?
RECORDATI RARE holds the South Korean marketing authorisation.